
Coronavirus update: Eli Lilly staffer tests positive, FDA postpones inspections and AACR is canceled as outbreak roils biopharma
The fallout from the fast-spreading coronavirus pandemic continues to be felt in the biopharma industry.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 148,300+ biopharma pros reading Endpoints daily — and it's free.